Medifocus Inc. reported earnings results for the second quarter and six months ended September 30, 2015. For the quarter, sales were USD 1,136,360, representing an increase of 1% from the previous three months ended June 30, 2015, and an increase of 77% from the same period in 2014. Operating loss was USD 957,807 compared to the same period in 2014, the operating loss for the quarter decreased USD 467,762, a 32% improvement, primarily due to the Prolieve cost restructuring implemented in August 2014.

For the six months, sales from the Prolieve® Thermodilatation System reached USD 2,261,370 for the six months ended September 30, 2015, a decrease of USD 29,796 from the same period of 2014. The loss of operation for the six months ended September 30, 2015 is USD 1,594,515, compared to a net loss of USD 2,479,070 in the same period of the previous year, a 36% improvement.